Follow the people · Insider
Sushil Patel
Sushil Patel files insider transactions with the SEC as a chief executive officer of Replimune Group (REPL). We hold 3 disclosed purchases and sales filed since 5 May 2021, 2 of them in the last 90 days.
- Files forREPL
- Disclosed buys and sells3 in all, 2 in the last 90 days
- Last disclosure12 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 May 2021 — 10 August 2026Chief Executive Officer · Replimune Group (REPL)23 Form 4 lines · source: SEC Form 4
- Filed 16 June 2022 — 29 June 2026Director · Revolution Medicines (RVMD)32 Form 4 lines · source: SEC Form 4
Everything they disclosed
55 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 39,341 shares of Replimune GroupSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- exercised options over 2,955 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 881 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- exercised options over 2,955 shares of Revolution Medicines (a derivative holding)SEC Form 41 July 2026Stock Option (Right to Buy) · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 300 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 900 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 1,100 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 858 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 300 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 100 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 600 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 541 shares of Revolution MedicinesSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- was granted 1,191 shares of Revolution MedicinesSEC Form 423 June 2026Common Stock · traded 18 June 2026 · filed 23 June 2026
- was granted 3,127 shares of Revolution Medicines (a derivative holding)SEC Form 423 June 2026Stock Option (Right to Buy) · traded 18 June 2026 · filed 23 June 2026
- ▼ sold on the open market 37,324 shares of Replimune GroupSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- was granted 251,240 shares of Replimune GroupSEC Form 47 April 2026Common Stock · traded 1 April 2026 · filed 7 April 2026
- was granted 376,860 shares of Replimune Group (a derivative holding)SEC Form 47 April 2026Employee Stock Option (right to buy) · traded 1 April 2026 · filed 7 April 2026
- was granted 200,000 shares of Replimune GroupSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- ▼ sold on the open market 10,000 shares of Replimune GroupSEC Form 44 December 2025Common Stock · traded 2 December 2025 · filed 4 December 2025
- was granted 11,574 shares of Revolution Medicines (a derivative holding)SEC Form 430 June 2025Stock Option (Right to Buy) · traded 26 June 2025 · filed 30 June 2025
- was granted 3,142 shares of Revolution MedicinesSEC Form 430 June 2025Common Stock · traded 26 June 2025 · filed 30 June 2025
- ▼ sold on the open market 25,105 shares of Replimune GroupSEC Form 422 May 2025Common Stock · traded 20 May 2025 · filed 22 May 2025
- was granted 250,000 shares of Replimune Group (a derivative holding)SEC Form 43 April 2025Employee Stock Option (right to buy) · traded 1 April 2025 · filed 3 April 2025
- was granted 166,667 shares of Replimune GroupSEC Form 43 April 2025Common Stock · traded 1 April 2025 · filed 3 April 2025
- ▼ sold on the open market 10,000 shares of Replimune GroupSEC Form 418 December 2024Common Stock · traded 16 December 2024 · filed 18 December 2024
- exercised options over 5,000 shares of Revolution Medicines (a derivative holding)SEC Form 44 November 2024Stock Option (Right to Buy) · traded 31 October 2024 · filed 4 November 2024
- exercised options over 5,000 shares of Revolution MedicinesSEC Form 44 November 2024Common Stock · traded 31 October 2024 · filed 4 November 2024
- ▼ sold on the open market 5,000 shares of Revolution MedicinesSEC Form 44 November 2024Common Stock · traded 31 October 2024 · filed 4 November 2024
- exercised options over 2,155 shares of Revolution Medicines (a derivative holding)SEC Form 410 July 2024Stock Option (Right to Buy) · traded 9 July 2024 · filed 10 July 2024
- exercised options over 2,155 shares of Revolution MedicinesSEC Form 410 July 2024Common Stock · traded 9 July 2024 · filed 10 July 2024
- ▼ sold on the open market 2,155 shares of Revolution MedicinesSEC Form 410 July 2024Common Stock · traded 9 July 2024 · filed 10 July 2024
- was granted 15,955 shares of Revolution Medicines (a derivative holding)SEC Form 428 June 2024Stock Option (Right to Buy) · traded 20 June 2024 · filed 28 June 2024
- was granted 4,248 shares of Revolution MedicinesSEC Form 428 June 2024Common Stock · traded 20 June 2024 · filed 28 June 2024
- was granted 16,700 shares of Revolution Medicines (a derivative holding)SEC Form 424 June 2024Stock Option (Right to Buy) · traded 20 June 2024 · filed 24 June 2024
- was granted 4,800 shares of Revolution MedicinesSEC Form 424 June 2024Common Stock · traded 20 June 2024 · filed 24 June 2024
- ▼ sold on the open market 20,194 shares of Replimune GroupSEC Form 420 May 2024Common Stock · traded 16 May 2024 · filed 20 May 2024
- exercised options over 2,155 shares of Revolution Medicines (a derivative holding)SEC Form 412 April 2024Stock Option (Right to Buy) · traded 10 April 2024 · filed 12 April 2024
- exercised options over 2,155 shares of Revolution MedicinesSEC Form 412 April 2024Common Stock · traded 10 April 2024 · filed 12 April 2024
- ▼ sold on the open market 2,155 shares of Revolution MedicinesSEC Form 412 April 2024Common Stock · traded 10 April 2024 · filed 12 April 2024
- was granted 250,000 shares of Replimune Group (a derivative holding)SEC Form 43 April 2024Employee Stock Option (right to buy) · traded 1 April 2024 · filed 3 April 2024
- was granted 83,335 shares of Replimune GroupSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
- ▼ sold on the open market 5,145 shares of Replimune GroupSEC Form 415 June 2023Common Stock · traded 13 June 2023 · filed 15 June 2023
- ▼ sold on the open market 553 shares of Replimune GroupSEC Form 415 June 2023Common Stock · traded 13 June 2023 · filed 15 June 2023
- was granted 18,400 shares of Revolution Medicines (a derivative holding)SEC Form 412 June 2023Stock Option (Right to Buy) · traded 8 June 2023 · filed 12 June 2023
- was granted 5,200 shares of Revolution MedicinesSEC Form 412 June 2023Common Stock · traded 8 June 2023 · filed 12 June 2023
- ▼ sold on the open market 15,575 shares of Replimune GroupSEC Form 418 May 2023Common Stock · traded 16 May 2023 · filed 18 May 2023
- was granted 60,000 shares of Replimune Group (a derivative holding)SEC Form 44 April 2023Employee Stock Option (right to buy) · traded 1 April 2023 · filed 4 April 2023
- was granted 40,000 shares of Replimune GroupSEC Form 44 April 2023Common Stock · traded 1 April 2023 · filed 4 April 2023
- was granted 36,800 shares of Revolution Medicines (a derivative holding)SEC Form 417 June 2022Stock Option (Right to Buy) · traded 16 June 2022 · filed 17 June 2022
- was granted 10,500 shares of Revolution MedicinesSEC Form 417 June 2022Common Stock · traded 16 June 2022 · filed 17 June 2022
- ▼ sold on the open market 10,687 shares of Replimune GroupSEC Form 418 May 2022Common Stock · traded 16 May 2022 · filed 18 May 2022
- was granted 78,750 shares of Replimune Group (a derivative holding)SEC Form 45 April 2022Employee Stock Option (right to buy) · traded 1 April 2022 · filed 5 April 2022
- was granted 52,500 shares of Replimune GroupSEC Form 45 April 2022Common Stock · traded 1 April 2022 · filed 5 April 2022
- was granted 88,333 shares of Replimune GroupSEC Form 45 May 2021Common Stock · traded 3 May 2021 · filed 5 May 2021
- was granted 125,000 shares of Replimune Group (a derivative holding)SEC Form 45 May 2021Employee Stock Option (right to buy) · traded 3 May 2021 · filed 5 May 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.